Results 21 to 30 of about 113,618,068 (200)
Clinical usefulness of cancer markers in primary breast cancer [PDF]
, 2011 The aim of this study was to investigate the diagnostic power of CA 549, MSA and CA 15-3 in identifying breast cancer. The study included 232 patients of which 56 were healthy, 43 had benign breast cancer and 191 with other growths.
Verring, A. +3 more
core +1 more source
South Eastern European Journal of Public Health, 2023 Aim: The aim of our study was to assess the association of carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) with socio-demographic factors and metastases site in women diagnosed with metastatic breast cancer in post-communist Albania. Methods: A case-series study was carried out during the period January 2010 – September 2017 including ...
Hoti, Adrian +3 more
openaire +1 more source
Case Reports in Oncology, 2021 A 73-year-old woman with no history of disease was referred to our hospital with fatigue and joint pain. Screening blood test showed that her cancer antigen 15-3 (CA 15-3) serum level was elevated to 36.6 U/mL, and a contrast-enhanced computed tomography
Koichiro Takayama +4 more
doaj +1 more source
International Journal of Research and Review, 2021 Introduction: Breast cancer is the most common malignancy in women. Progressivity of breast cancer evaluated through examination of tumor markers. Serum Ca 15-3 is tumor markers used to assess the progression. Various treatments have been developed to suppress the progression, one of which the provision of plant extractions. Extracts of Allium sativum,
Agnes Santoso +2 more
openaire +1 more source
Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: Pretreatment levels or kinetics during chemotherapy? [PDF]
, 2007 Background: The carbohydrate antigen 19-9 (CA 19-9) is currently the most widely used serum tumor marker in pancreatic cancer (PC). CA 19-9 pretreatment levels as well as CA 19-9 kinetics during systemic chemotherapy can provide prognostic information ...
Holdenrieder, Stefan +5 more
core +1 more source
Journal of Applied Sciences and Environmental Management, 2023 Breast cancer represents the most common neoplastic disease in females, accounting for up to one third of new diagnoses of women’s cancer in certain regions of the world.
U. Okeke, J. B. Minari, J. Okpuzor
doaj +1 more source
Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes [PDF]
, 2008 BACKGROUND: To investigate the association between tumor markers [cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA)] and clinicopathological parameters and patient outcomes in breast cancer.
김주희 +3 more
core +1 more source
Serum miR-16 and CA15.3 combination as early diagnostic biomarkers for breast cancer in Egyptian females [PDF]
Egyptian Journal of Pure and Applied ScienceBackground: Breast cancer (BC) represents one of the most lethal malignancies among women worldwide. MiRNAs play an important role in breast cancer diagnosis and progression. Inconsistent data about the expression level of miR-16 was reported in BC, thus
Sara Kamal +3 more
doaj +1 more source
Tumor markers in breast cancer - European Group on Tumor Markers recommendations [PDF]
, 2005 Recommendations are presented for the routine clinical use of serum and tissue-based markers in the diagnosis and management of patients with breast cancer.
Einarsson, Roland +10 more
core +1 more source
The Use of Carbohydrate Antigen (CA) 15-3 as a Tumor Marker in Detecting Breast Cancer
Pakistan Journal of Biological Sciences, 2008 This study was carried out to determine the sensitivity and specificity of serum CA 15-3 as a marker in detecting and monitoring treatment in, breast cancer patients. One hundred and ten patients comprising 35 known breast cancer patients, 75 suspected cases and 20 controls entered the study. Blood samples were taken before and after treatment from the
M T, Agyei Frempong +2 more
openaire +2 more sources